{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T08:43:02Z","timestamp":1792312982905,"version":"4.4.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,9,11]],"date-time":"2018-09-11T00:00:00Z","timestamp":1536624000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Strahlenther Onkol"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1007\/s00066-018-1367-2","type":"journal-article","created":{"date-parts":[[2018,9,11]],"date-time":"2018-09-11T16:05:12Z","timestamp":1536681912000},"page":"93-102","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":55,"title":["Efficacy of stereotactic body radiotherapy for unresectable or recurrent cholangiocarcinoma: a\u00a0meta-analysis and systematic review","Wirksamkeit der stereotaktischen Strahlentherapie bei nichtresektablem oder rezidivierendem Cholangiokarzinom: eine Metaanalyse und systematische \u00dcbersicht"],"prefix":"10.1007","volume":"195","author":[{"given":"Jeongshim","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Won Sup","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woong Sub","family":"Koom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chai Hong","family":"Rim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,9,11]]},"reference":[{"key":"1367_CR1","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/0360-3016(94)90115-5","volume":"28","author":"ME Alden","year":"1994","unstructured":"Alden ME, Mohiuddin M (1994) The impact of radiation dose in combined external beam and intraluminal Ir-192 brachytherapy for bile duct cancer. Int J Radiat Oncol Biol Phys 28:945\u2013951","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1367_CR2","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/1748-717X-7-67","volume":"7","author":"BM Barney","year":"2012","unstructured":"Barney BM, Olivier KR, Miller RC et\u00a0al (2012) Clinical outcomes and toxicity using stereotactic body radiotherapy (SBRT) for advanced cholangiocarcinoma. Radiat Oncol 7:67","journal-title":"Radiat Oncol"},{"key":"1367_CR3","doi-asserted-by":"publisher","first-page":"8739","DOI":"10.1200\/JCO.2005.01.5354","volume":"23","author":"E Ben-Josef","year":"2005","unstructured":"Ben-Josef E, Normolle D, Ensminger WD et al (2005) Phase II trial of high-dose conformal radiation therapy with concurrent hepatic artery floxuridine for unresectable intrahepatic malignancies. J\u00a0Clin Oncol 23:8739\u20138747","journal-title":"J Clin Oncol"},{"key":"1367_CR4","doi-asserted-by":"publisher","first-page":"4078","DOI":"10.1118\/1.3438081","volume":"37","author":"SH Benedict","year":"2010","unstructured":"Benedict SH, Yenice KM, Followill D et\u00a0al (2010) Stereotactic body radiation therapy: the report of AAPM Task Group 101. Med Phys 37:4078\u20134101","journal-title":"Med Phys"},{"key":"1367_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ije\/28.1.1","volume":"28","author":"M Blettner","year":"1999","unstructured":"Blettner M, Sauerbrei W, Schlehofer B et al (1999) Traditional reviews, meta-analyses and pooled analyses in epidemiology. Int J Epidemiol 28:1\u20139","journal-title":"Int J Epidemiol"},{"key":"1367_CR6","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1200\/JCO.2012.44.1659","volume":"31","author":"A Bujold","year":"2013","unstructured":"Bujold A, Massey CA, Kim JJ et\u00a0al (2013) Sequential phase I and II trials of stereotactic body radiotherapy for locally advanced hepatocellular carcinoma. J\u00a0Clin Oncol 31:1631\u20131639","journal-title":"J Clin Oncol"},{"key":"1367_CR7","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1186\/1471-2407-10-492","volume":"10","author":"Y-X Chen","year":"2010","unstructured":"Chen Y\u2011X, Zeng Z\u2011C, Tang Z\u2011Y et al (2010) Determining the role of external beam radiotherapy in unresectable intrahepatic cholangiocarcinoma: a\u00a0retrospective analysis of 84 patients. BMC Cancer 10:492","journal-title":"BMC Cancer"},{"key":"1367_CR8","doi-asserted-by":"publisher","first-page":"101","DOI":"10.2307\/3001666","volume":"10","author":"WG Cochran","year":"1954","unstructured":"Cochran WG (1954) The combination of estimates from different experiments. Biometrics 10:101\u2013129","journal-title":"Biometrics"},{"key":"1367_CR9","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/S0360-3016(02)02845-6","volume":"53","author":"CH Crane","year":"2002","unstructured":"Crane CH, Macdonald KO, Vauthey JN et\u00a0al (2002) Limitations of conventional doses of chemoradiation for unresectable biliary cancer. Int J Radiat Oncol Biol Phys 53:969\u2013974","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1367_CR10","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.cct.2006.04.004","volume":"28","author":"R DerSimonian","year":"2007","unstructured":"DerSimonian R, Kacker R (2007) Random-effects model for meta-analysis of clinical trials: an update. Contemp Clin Trials 28:105\u2013114","journal-title":"Contemp Clin Trials"},{"key":"1367_CR11","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.canrad.2011.06.005","volume":"16","author":"S Dewas","year":"2012","unstructured":"Dewas S, Mirabel X, Kramar A et\u00a0al (2012) Stereotactic body radiation therapy for liver primary and metastases: the Lille experience. Cancer Radiother 16:58\u201369","journal-title":"Cancer Radiother"},{"key":"1367_CR12","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Smith GD, Schneider M et al (1997) Bias in meta-analysis detected by a\u00a0simple, graphical test. BMJ 315:629\u2013634","journal-title":"BMJ"},{"key":"1367_CR13","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/0360-3016(91)90171-Y","volume":"21","author":"B Emami","year":"1991","unstructured":"Emami B, Lyman J, Brown A et\u00a0al (1991) Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 21:109\u2013122","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1367_CR14","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1001\/jamaoncol.2017.2303","volume":"4","author":"M Feng","year":"2018","unstructured":"Feng M, Suresh K, Schipper MJ et\u00a0al (2018) Individualized adaptive stereotactic body radiotherapy for liver tumors in patients at high risk for liver damage: a phase 2 clinical trial. Jama Oncol 4:40\u201347","journal-title":"Jama Oncol"},{"key":"1367_CR15","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1016\/j.jhep.2011.12.001","volume":"56","author":"European Association For The Study Of The Liver","year":"2012","unstructured":"European Association For The Study Of The Liver, European Organisation For Research And Treatment Of Cancer (2012) EASL\u2013EORTC clinical practice guidelines: management of hepatocellular carcinoma. J\u00a0Hepatol 56:908\u2013943","journal-title":"J Hepatol"},{"key":"1367_CR16","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s00066-013-0450-y","volume":"190","author":"M Guckenberger","year":"2014","unstructured":"Guckenberger M, Andratschke N, Alheit H et al (2014) Definition of stereotactic body radiotherapy: principles and practice for the treatment of stage I non-small cell lung cancer. Strahlenther Onkol 190:26\u201333","journal-title":"Strahlenther Onkol"},{"key":"1367_CR17","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.radonc.2007.01.012","volume":"83","author":"M Guckenberger","year":"2007","unstructured":"Guckenberger M, Meyer J, Wilbert J et al (2007) Intra-fractional uncertainties in cone-beam CT based image-guided radiotherapy (IGRT) of pulmonary tumors. Radiother Oncol 83:57\u201364","journal-title":"Radiother Oncol"},{"key":"1367_CR18","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.ijrobp.2008.01.005","volume":"71","author":"M Guckenberger","year":"2008","unstructured":"Guckenberger M, Sweeney RA, Wilbert J et al (2008) Image-guided radiotherapy for liver cancer using respiratory-correlated computed tomography and cone-beam computed tomography. Int J Radiat Oncol Biol Phys 71:297\u2013304","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1367_CR19","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1097\/01.tp.0000253551.43583.d1","volume":"82","author":"JK Heimbach","year":"2006","unstructured":"Heimbach JK, Gores GJ, Haddock MG et\u00a0al (2006) Predictors of disease recurrence following neoadjuvant chemoradiotherapy and liver transplantation for unresectable perihilar cholangiocarcinoma. Transplantation 82:1703\u20131707","journal-title":"Transplantation"},{"key":"1367_CR20","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1200\/JCO.2015.64.2710","volume":"34","author":"TS Hong","year":"2016","unstructured":"Hong TS, Wo JY, Yeap BY et al (2016) Multi-institutional phase II study of high-dose Hypofractionated proton beam therapy in patients with localized, Unresectable Hepatocellular carcinoma and Intrahepatic Cholangiocarcinoma. J\u00a0Clin Oncol 34:460\u2013468","journal-title":"J Clin Oncol"},{"key":"1367_CR21","doi-asserted-by":"publisher","first-page":"575","DOI":"10.3109\/0284186X.2011.652736","volume":"51","author":"RA Ibarra","year":"2012","unstructured":"Ibarra RA, Rojas D, Snyder L et al (2012) Multicenter results of stereotactic body radiotherapy (SBRT) for non-resectable primary liver tumors. Acta Oncol 51:575\u2013583","journal-title":"Acta Oncol"},{"key":"1367_CR22","doi-asserted-by":"publisher","first-page":"163","DOI":"10.3857\/roj.2014.32.3.163","volume":"32","author":"DH Jung","year":"2014","unstructured":"Jung DH, Kim MS, Cho CK et\u00a0al (2014) Outcomes of stereotactic body radiotherapy for unresectable primary or recurrent cholangiocarcinoma. Radiat Oncol\u00a0J 32:163\u2013169","journal-title":"Radiat Oncol J"},{"key":"1367_CR23","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.cgh.2007.12.004","volume":"6","author":"M Kahaleh","year":"2008","unstructured":"Kahaleh M, Mishra R, Shami VM et\u00a0al (2008) Unresectable Cholangiocarcinoma: comparison of survival in Biliary Stenting alone versus Stenting with Photodynamic therapy. Clin Gastroenterol Hepatol 6:290\u2013297","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1367_CR24","doi-asserted-by":"publisher","first-page":"5424","DOI":"10.1002\/cncr.27533","volume":"118","author":"JK Kang","year":"2012","unstructured":"Kang JK, Kim MS, Cho CK et\u00a0al (2012) Stereotactic body radiation therapy for inoperable hepatocellular carcinoma as a\u00a0local salvage treatment after incomplete transarterial chemoembolization. Cancer 118:5424\u20135431","journal-title":"Cancer"},{"key":"1367_CR25","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1016\/S0140-6736(05)67530-7","volume":"366","author":"SA Khan","year":"2005","unstructured":"Khan SA, Thomas HC, Davidson BR et\u00a0al (2005) Cholangiocarcinoma. Lancet 366:1303\u20131314","journal-title":"Lancet"},{"key":"1367_CR26","first-page":"1298","volume":"48","author":"MW Kim","year":"2001","unstructured":"Kim MW, Kim WH, Wang HJ et\u00a0al (2001) The experiences of hilar skeletonization for the treatment of locally advanced proximal bile duct cancer. Hepatogastroenterology 48:1298\u20131301","journal-title":"Hepatogastroenterology"},{"key":"1367_CR27","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.radonc.2009.11.004","volume":"94","author":"N Kopek","year":"2010","unstructured":"Kopek N, Holt MI, Hansen AT et\u00a0al (2010) Stereotactic body radiotherapy for unresectable cholangiocarcinoma. Radiother Oncol 94:47\u201352","journal-title":"Radiother Oncol"},{"key":"1367_CR28","doi-asserted-by":"publisher","first-page":"e443","DOI":"10.1016\/j.prro.2015.02.007","volume":"5","author":"FD Lasley","year":"2015","unstructured":"Lasley FD, Mannina EM, Johnson CS et al (2015) Treatment variables related to liver toxicity in patients with hepatocellular carcinoma, Child-Pugh class A and B enrolled in a\u00a0phase 1\u20132 trial of stereotactic body radiation therapy. Pract Radiat Oncol 5:e443\u2013e449","journal-title":"Pract Radiat Oncol"},{"key":"1367_CR29","doi-asserted-by":"publisher","first-page":"236","DOI":"10.5301\/tj.5000588","volume":"103","author":"MY Liu","year":"2017","unstructured":"Liu MY, Lo CH, Lin CS et\u00a0al (2017) Stereotactic ablative radiotherapy for patients with unresectable or medically inoperable cholangiocarcinoma. Tumori 103:236\u2013241","journal-title":"Tumori"},{"key":"1367_CR30","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1002\/jso.24833","volume":"117","author":"BPT Loveday","year":"2018","unstructured":"Loveday BPT, Knox JJ, Dawson LA et\u00a0al (2018) Neoadjuvant hyperfractionated chemoradiation and liver transplantation for unresectable perihilar cholangiocarcinoma in Canada. J\u00a0Surg Oncol 117:213\u2013219","journal-title":"J Surg Oncol"},{"key":"1367_CR31","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.7150\/jca.13032","volume":"6","author":"A Mahadevan","year":"2015","unstructured":"Mahadevan A, Dagoglu N, Mancias J et\u00a0al (2015) Stereotactic Body Radiotherapy (SBRT) for Intrahepatic and Hilar Cholangiocarcinoma. J\u00a0Cancer 6:1099\u20131104","journal-title":"J Cancer"},{"key":"1367_CR32","doi-asserted-by":"publisher","first-page":"e615","DOI":"10.1016\/j.ijrobp.2011.04.045","volume":"81","author":"A Mahadevan","year":"2011","unstructured":"Mahadevan A, Miksad R, Goldstein M et\u00a0al (2011) Induction gemcitabine and stereotactic body radiotherapy for locally advanced nonmetastatic pancreas cancer. Int J Radiat Oncol Biol Phys 81:e615\u2013622","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1367_CR33","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/1748-717X-9-26","volume":"9","author":"C Makita","year":"2014","unstructured":"Makita C, Nakamura T, Takada A et\u00a0al (2014) Clinical outcomes and toxicity of proton beam therapy for advanced cholangiocarcinoma. Radiat Oncol 9:26","journal-title":"Radiat Oncol"},{"key":"1367_CR34","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.critrevonc.2008.09.008","volume":"69","author":"S Mosconi","year":"2009","unstructured":"Mosconi S, Beretta GD, Labianca R et\u00a0al (2009) Cholangiocarcinoma. Crit Rev Oncol Hematol 69:259\u2013270","journal-title":"Crit Rev Oncol Hematol"},{"key":"1367_CR35","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/nrgastro.2011.20","volume":"8","author":"T Patel","year":"2011","unstructured":"Patel T (2011) Cholangiocarcinoma\u2014controversies and challenges. Nat Rev Gastroenterol Hepatol 8:189\u2013200","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1367_CR36","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.radonc.2011.05.016","volume":"99","author":"FA Polistina","year":"2011","unstructured":"Polistina FA, Guglielmi R, Baiocchi C et al (2011) Chemoradiation treatment with gemcitabine plus stereotactic body radiotherapy for unresectable, non-metastatic, locally advanced hilar cholangiocarcinoma. Results of a\u00a0five year experience. Radiother Oncol 99:120\u2013123","journal-title":"Radiother Oncol"},{"key":"1367_CR37","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.ijrobp.2009.09.042","volume":"76","author":"L Potters","year":"2010","unstructured":"Potters L, Kavanagh B, Galvin JM et\u00a0al (2010) American Society for Therapeutic Radiology and Oncology (ASTRO) and American College of Radiology (ACR) practice guideline for the performance of stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys 76:326\u2013332","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1367_CR38","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/01.sla.0000179678.13285.fa","volume":"242","author":"DJ Rea","year":"2005","unstructured":"Rea DJ, Heimbach JK, Rosen CB et\u00a0al (2005) Liver transplantation with neoadjuvant chemoradiation is more effective than resection for hilar cholangiocarcinoma. Ann Surg 242:451\u2013458 (discussion 458\u2013461)","journal-title":"Ann Surg"},{"key":"1367_CR39","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.adro.2016.10.008","volume":"1","author":"KA Sandler","year":"2016","unstructured":"Sandler KA, Veruttipong D, Agopian VG et\u00a0al (2016) Stereotactic body radiotherapy (SBRT) for locally advanced extrahepatic and intrahepatic cholangiocarcinoma. Adv Radiat Oncol 1:237\u2013243","journal-title":"Adv Radiat Oncol"},{"key":"1367_CR40","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1007\/s00432-015-1929-y","volume":"141","author":"M Scorsetti","year":"2015","unstructured":"Scorsetti M, Comito T, Cozzi L et al (2015) The challenge of inoperable hepatocellular carcinoma (HCC): results of a\u00a0single-institutional experience on stereotactic body radiation therapy (SBRT). J\u00a0Cancer Res Clin Oncol 141:1301\u20131309","journal-title":"J Cancer Res Clin Oncol"},{"key":"1367_CR41","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1016\/j.ijrobp.2008.03.018","volume":"72","author":"ET Shinohara","year":"2008","unstructured":"Shinohara ET, Mitra N, Guo M et\u00a0al (2008) Radiation therapy is associated with improved survival in the adjuvant and definitive treatment of intrahepatic cholangiocarcinoma. Int J Radiat Oncol Biol Phys 72:1495\u20131501","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1367_CR42","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1007\/s00066-014-0714-1","volume":"190","author":"F Sterzing","year":"2014","unstructured":"Sterzing F, Brunner TB, Ernst I et\u00a0al (2014) Stereotactic body radiotherapy for liver tumors: principles and practical guidelines of the DEGRO Working Group on Stereotactic Radiotherapy. Strahlenther Onkol 190:872\u2013881","journal-title":"Strahlenther Onkol"},{"key":"1367_CR43","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","volume":"283","author":"DF Stroup","year":"2000","unstructured":"Stroup DF, Berlin JA, Morton SC et al (2000) Meta-analysis of observational studies in epidemiology: a\u00a0proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 283:2008\u20132012","journal-title":"JAMA"},{"key":"1367_CR44","doi-asserted-by":"publisher","DOI":"10.1007\/s00268-018-4558-1","author":"T Sumiyoshi","year":"2018","unstructured":"Sumiyoshi T, Shima Y, Okabayashi T et\u00a0al (2018) Chemoradiotherapy for initially Unresectable locally advanced Cholangiocarcinoma. World J Surg. https:\/\/doi.org\/10.1007\/s00268-018-4558-1","journal-title":"World J Surg"},{"key":"1367_CR45","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1200\/JCO.2015.61.3778","volume":"34","author":"R Tao","year":"2016","unstructured":"Tao R, Krishnan S, Bhosale PR et\u00a0al (2016) Ablative radiotherapy doses lead to a\u00a0substantial prolongation of survival in patients with inoperable Intrahepatic Cholangiocarcinoma: a retrospective dose response analysis. J\u00a0Clin Oncol 34:219\u2013226","journal-title":"J Clin Oncol"},{"key":"1367_CR46","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","volume":"92","author":"P Therasse","year":"2000","unstructured":"Therasse P, Arbuck SG, Eisenhauer EA et\u00a0al (2000) New guidelines to evaluate the response to treatment in solid tumors. J\u00a0Natl Cancer Inst 92:205\u2013216","journal-title":"J Natl Cancer Inst"},{"key":"1367_CR47","doi-asserted-by":"publisher","first-page":"4001","DOI":"10.1245\/s10434-017-6131-9","volume":"24","author":"A Torgeson","year":"2017","unstructured":"Torgeson A, Lloyd S, Boothe D et al (2017) Chemoradiation therapy for Unresected Extrahepatic Cholangiocarcinoma: a propensity score-matched analysis. Ann Surg Oncol 24:4001\u20134008","journal-title":"Ann Surg Oncol"},{"key":"1367_CR48","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3322\/caac.21262","volume":"65","author":"LA Torre","year":"2015","unstructured":"Torre LA, Bray F, Siegel RL et\u00a0al (2015) Global cancer statistics, 2012. Ca Cancer J Clin 65:87\u2013108","journal-title":"Ca Cancer J Clin"},{"key":"1367_CR49","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1200\/JCO.2007.14.3529","volume":"26","author":"RV Tse","year":"2008","unstructured":"Tse RV, Hawkins M, Lockwood G et\u00a0al (2008) Phase I study of individualized stereotactic body radiotherapy for hepatocellular carcinoma and intrahepatic cholangiocarcinoma. J\u00a0Clin Oncol 26:657\u2013664","journal-title":"J Clin Oncol"},{"key":"1367_CR50","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.radonc.2016.07.020","volume":"121","author":"AA Weiner","year":"2016","unstructured":"Weiner AA, Olsen J, Ma D et\u00a0al (2016) Stereotactic body radiotherapy for primary hepatic malignancies\u2014Report of a\u00a0phase I\/II institutional study. Radiother Oncol 121:79\u201385","journal-title":"Radiother Oncol"},{"key":"1367_CR51","volume-title":"The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses","author":"GSB Wells","year":"2009","unstructured":"Wells GSB, O\u2019connell D, Peterson J, Welch V, Losos M (2009) The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa Hospital Research Institute, Oxford, Ottawa"},{"key":"1367_CR52","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.ijrobp.2014.05.007","volume":"90","author":"Q Xu","year":"2014","unstructured":"Xu Q, Hanna G, Grimm J et\u00a0al (2014) Quantifying rigid and nonrigid motion of liver tumors during stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys 90:94\u2013101","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1367_CR53","first-page":"113","volume":"12","author":"ZC Zeng","year":"2006","unstructured":"Zeng ZC, Tang ZY, Fan J et\u00a0al (2006) Consideration of the role of radiotherapy for unresectable intrahepatic cholangiocarcinoma: a\u00a0retrospective analysis of 75 patients. Cancer\u00a0J 12:113\u2013122","journal-title":"Cancer J"}],"container-title":["Strahlentherapie und Onkologie"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00066-018-1367-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-018-1367-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-018-1367-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T02:52:39Z","timestamp":1662000759000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00066-018-1367-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,11]]},"references-count":53,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["1367"],"URL":"https:\/\/doi.org\/10.1007\/s00066-018-1367-2","relation":{},"ISSN":["0179-7158","1439-099X"],"issn-type":[{"value":"0179-7158","type":"print"},{"value":"1439-099X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,11]]},"assertion":[{"value":"5 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.\u00a0Lee, W.S.\u00a0Yoon, W.S.\u00a0Koom and C.H.\u00a0Rim declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}